DGX Quest Diagnostics
- 149.350
- +0.350+0.23%
- 149.350
- 0.0000.00%
Quest Diagnostics News
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director RING TIMOTHY M
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer GARDNER MARK A
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer PREVOZNIK MICHAEL E
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer KUPPUSAMY KARTHIK
Quest Diagnostics | 8-K: Quest Diagnostics Completes Acquisition of LifeLabs,Enhancing Access to Diagnostic Innovation
Quest Diagnostics | 144: Notice of proposed sale of securities pursuant to Rule 144
Quest Diagnostics | 144: Notice of proposed sale of securities pursuant to Rule 144
Quest Diagnostics | 8-K: Quest Diagnostics Prices $1.85 Billion of Senior Notes
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer KUPPUSAMY KARTHIK
Quest Diagnostics | 424B2: Prospectus
Quest Diagnostics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Quest Diagnostics | 424B2: Prospectus
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer DELANEY MARK E
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer SAMAD SAM
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer KUPPUSAMY KARTHIK
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Plewman Patrick
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Gregg Vicky B
Quest Diagnostics | 10-Q: Q2 2024 Earnings Report
Quest Diagnostics | 144: Notice of proposed sale of securities pursuant to Rule 144
Quest Diagnostics | 8-K: Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
Analysis
Price Target
No Data
No Data
